Literature DB >> 21376639

A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.

Kwok S Wun1, Garth Cameron, Onisha Patel, Siew Siew Pang, Daniel G Pellicci, Lucy C Sullivan, Santosh Keshipeddy, Mary H Young, Adam P Uldrich, Meena S Thakur, Stewart K Richardson, Amy R Howell, Petr A Illarionov, Andrew G Brooks, Gurdyal S Besra, James McCluskey, Laurent Gapin, Steven A Porcelli, Dale I Godfrey, Jamie Rossjohn.   

Abstract

Natural killer T (NKT) cells respond to a variety of CD1d-restricted antigens (Ags), although the basis for Ag discrimination by the NKT cell receptor (TCR) is unclear. Here we have described NKT TCR fine specificity against several closely related Ags, termed altered glycolipid ligands (AGLs), which differentially stimulate NKT cells. The structures of five ternary complexes all revealed similar docking. Acyl chain modifications did not affect the interaction, but reduced NKT cell proliferation, indicating an affect on Ag processing or presentation. Conversely, truncation of the phytosphingosine chain caused an induced fit mode of TCR binding that affected TCR affinity. Modifications in the glycosyl head group had a direct impact on the TCR interaction and associated cellular response, with ligand potency reflecting the t(1/2) life of the interaction. Accordingly, we have provided a molecular basis for understanding how modifications in AGLs can result in striking alterations in the cellular response of NKT cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376639      PMCID: PMC3064745          DOI: 10.1016/j.immuni.2011.02.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  40 in total

Review 1.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 2.  The biology of NKT cells.

Authors:  Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

3.  A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule.

Authors:  Fleur E Tynan; Hugh H Reid; Lars Kjer-Nielsen; John J Miles; Matthew C J Wilce; Lyudmila Kostenko; Natalie A Borg; Nicholas A Williamson; Travis Beddoe; Anthony W Purcell; Scott R Burrows; James McCluskey; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2007-01-28       Impact factor: 25.606

Review 4.  CD1d ligands: the good, the bad, and the ugly.

Authors:  Randy R Brutkiewicz
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

5.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.

Authors:  Karl O A Yu; Jin S Im; Alberto Molano; Yves Dutronc; Petr A Illarionov; Claire Forestier; Nagatoshi Fujiwara; Isa Arias; Sachiko Miyake; Takashi Yamamura; Young-Tae Chang; Gurdyal S Besra; Steven A Porcelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-18       Impact factor: 11.205

6.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

7.  Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.

Authors:  Thierry Mallevaey; Josette Fontaine; Laetitia Breuilh; Christophe Paget; Alexandre Castro-Keller; Catherine Vendeville; Monique Capron; Maria Leite-de-Moraes; François Trottein; Christelle Faveeuw
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

8.  A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.

Authors:  Lars Kjer-Nielsen; Natalie A Borg; Daniel G Pellicci; Travis Beddoe; Lyudmila Kostenko; Craig S Clements; Nicholas A Williamson; Mark J Smyth; Gurdyal S Besra; Hugh H Reid; Mandvi Bharadwaj; Dale I Godfrey; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2006-02-27       Impact factor: 14.307

9.  Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide.

Authors:  John Schmieg; Guangli Yang; Richard W Franck; Moriya Tsuji
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

10.  The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.

Authors:  Corinna McCarthy; Dawn Shepherd; Sebastian Fleire; Victoria S Stronge; Michael Koch; Petr A Illarionov; Giovanna Bossi; Mariolina Salio; Galit Denkberg; Faye Reddington; Andrea Tarlton; B Gopal Reddy; Richard R Schmidt; Yoram Reiter; Gillian M Griffiths; P Anton van der Merwe; Gurdyal S Besra; E Yvonne Jones; Facundo D Batista; Vincenzo Cerundolo
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

View more
  80 in total

1.  The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides.

Authors:  Lisa Kain; Bill Webb; Brian L Anderson; Shenglou Deng; Marie Holt; Anne Costanzo; Anne Constanzo; Meng Zhao; Kevin Self; Anais Teyton; Chris Everett; Mitchell Kronenberg; Dirk M Zajonc; Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.

Authors:  Esther Dawen Yu; Enrico Girardi; Jing Wang; Thien-Thi Mac; Karl O A Yu; Serge Van Calenbergh; Steven A Porcelli; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

3.  Beta-testing NKT cell self-reactivity.

Authors:  Dale I Godfrey; Daniel G Pellicci; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

Review 4.  Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Authors:  Victoria Lawson
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

5.  Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.

Authors:  Jerome Kerzerho; Esther D Yu; Carolina M Barra; Elisenda Alari-Pahissa; Elisenda Alari-Pahisa; Enrico Girardi; Youssef Harrak; Pilar Lauzurica; Amadeu Llebaria; Dirk M Zajonc; Omid Akbari; A Raúl Castaño
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

6.  Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.

Authors:  Onisha Patel; Daniel G Pellicci; Adam P Uldrich; Lucy C Sullivan; Mugdha Bhati; Melissa McKnight; Stewart K Richardson; Amy R Howell; Thierry Mallevaey; Jingjing Zhang; Romain Bedel; Gurdyal S Besra; Andrew G Brooks; Lars Kjer-Nielsen; James McCluskey; Steven A Porcelli; Laurent Gapin; Jamie Rossjohn; Dale I Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 7.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

Review 8.  Lipid and small-molecule display by CD1 and MR1.

Authors:  Ildiko Van Rhijn; Dale I Godfrey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

9.  Antigen-dependent versus -independent activation of invariant NKT cells during infection.

Authors:  Keli L Holzapfel; Aaron J Tyznik; Mitchell Kronenberg; Kristin A Hogquist
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

Review 10.  The CD1 size problem: lipid antigens, ligands, and scaffolds.

Authors:  Dalam Ly; D Branch Moody
Journal:  Cell Mol Life Sci       Date:  2014-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.